Long-term Complications in Patients with Childhood-onset Nephrotic Syndrome

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2022 Aug 9

PMID 35943575

Authors

Joyita Bharati

Karalanglin Tiewsoh

Lesa Dawman

Tarvinder Singh

Ujjwal Gorsi

Arun Prabhahar Rajarajen

Aakanksha Sharma

Rahul Chanchlani

Raja Ramachandran

Harbir Singh Kohli

Affiliations

Soon will be listed here.

Abstract

Background: Reports on long-term complications of childhood-onset nephrotic syndrome (NS), such as obesity, osteoporosis, growth failure, and hypertension, are mostly from developed countries not representing South Asian ethnicities. Furthermore, data on cardiovascular health among patients with childhood-onset NS are limited.

Methods: This was an observational study involving patients attending a tertiary care center. Patients aged 15 years and older were examined for long-term complications and remission of NS at their visit in December 2021. Childhood-onset NS meant onset of NS before 10 years of age. Long-term complications included obesity, growth failure, low bone mineral density (BMD) Z score, hypertension, and increased carotid intima-media thickness (cIMT). Long-term remission was defined as no relapse for the last [Formula: see text] 3 consecutive years without immunosuppressive medication to maintain remission.

Results: Of 101 patients studied (~ 80% with frequent relapsing (FR)/steroid-dependent (SD) NS), the mean age was 17.6 (± 2.4) years at the time of study. Long-term complications were noted in 89.1% of patients which included one or more of the following: obesity (22.7%), growth failure (31.7%), low BMD Z score (53.5%), hypertension (31.7%), and high cIMT (50.5%). Thirty-nine patients (38.6%) were in long-term remission at the time of the study. Growth failure and low BMD Z scores were less frequent in patients with long-term remission compared to those without long-term remission.

Conclusions: In patients with childhood-onset NS (predominantly FR/SDNS) who were studied at [Formula: see text] 15 years of age, ~ 90% had long-term complications which included high cIMT in 50%. Only ~ 40% were in long-term remission. A higher resolution version of the Graphical abstract is available as Supplementary information.

Citing Articles

To biopsy or not to biopsy a teenager with typical idiopathic nephrotic syndrome? Start steroids first.

Boyer O, Bernardi S, Preka E Pediatr Nephrol. 2024; 40(2):579-585.

PMID: 39259322 DOI: 10.1007/s00467-024-06447-w.

Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.

Mohamad K, Zainal H, Abdul Rahim N, Tengku Hussain T J Nephrol. 2024; 37(9):2551-2559.

PMID: 39218996 DOI: 10.1007/s40620-024-02076-6.

References

Ruth E, Kemper M, Leumann E, Laube G, Neuhaus T . Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005; 147(2):202-7. DOI: 10.1016/j.jpeds.2005.03.050. View

Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M . Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood. Clin Nephrol. 2013; 81(3):166-73. DOI: 10.5414/CN108044. View

Hjorten R, Anwar Z, Reidy K . Long-term Outcomes of Childhood Onset Nephrotic Syndrome. Front Pediatr. 2016; 4:53. PMC: 4879783. DOI: 10.3389/fped.2016.00053. View

Kniazewska M, Obuchowicz A, Wielkoszynski T, Zmudzinska-Kitczak J, Urban K, Marek M . Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol. 2008; 24(3):549-54. DOI: 10.1007/s00467-008-1029-1. View

Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux M, Landais P . Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis. 2003; 41(3):550-7. DOI: 10.1053/ajkd.2003.50116. View

Banh T, Hussain-Shamsy N, Patel V, Vasilevska-Ristovska J, Borges K, Sibbald C . Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome. Clin J Am Soc Nephrol. 2016; 11(10):1760-1768. PMC: 5053779. DOI: 10.2215/CJN.00380116. View

Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A . Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Kidney Int. 2018; 95(1):210-218. DOI: 10.1016/j.kint.2018.08.039. View

Touboul P, Hennerici M, Meairs S, Adams H, Amarenco P, Bornstein N . Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2006; 23(1):75-80. DOI: 10.1159/000097034. View

Kasliwal R, Bansal M, Desai N, Kotak B, Raza A, Vasnawala H . A Study to derive distribution of carotid intima media thickness and to determine its COrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population (SCORE-India). Indian Heart J. 2016; 68(6):821-827. PMC: 5143805. DOI: 10.1016/j.ihj.2016.04.009. View

10.

Varni J, Seid M, Kurtin P . PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001; 39(8):800-12. DOI: 10.1097/00005650-200108000-00006. View

11.

Kabuki N, Okugawa T, Hayakawa H, Tomizawa S, Kasahara T, Uchiyama M . Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 1998; 12(6):467-70. DOI: 10.1007/s004670050489. View

12.

Laine C, Laine T . Diagnosis of Osteoporosis in Children and Adolescents. Eur Endocrinol. 2018; 9(2):141-144. PMC: 6003589. DOI: 10.17925/EE.2013.09.02.141. View

13.

Gordon C, Leonard M, Zemel B . 2013 Pediatric Position Development Conference: executive summary and reflections. J Clin Densitom. 2014; 17(2):219-24. DOI: 10.1016/j.jocd.2014.01.007. View

14.

Lewis M, Baildom E, Davis N, Houston I, Postlethwaite R . Nephrotic syndrome: from toddlers to twenties. Lancet. 1989; 1(8632):255-9. DOI: 10.1016/s0140-6736(89)91266-x. View

15.

Shatat I, Schoeneman M, Flynn J, Woroniecki R . Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis. Pediatr Nephrol. 2007; 22(6):834-9. DOI: 10.1007/s00467-006-0413-y. View

16.

Keshri S, Sharma S, Agrawal N, Bansal S, Guilliani B, Aggrawal K . Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remission. Clin Exp Nephrol. 2018; 22(5):1157-1162. DOI: 10.1007/s10157-018-1565-3. View

17.

Davis P, Dawson J, RILEY W, Lauer R . Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation. 2001; 104(23):2815-9. DOI: 10.1161/hc4601.099486. View

18.

Skrzypczyk P, Kuzma-Mroczkowska E, Kulagowska J, Brzewski M, Okarska-Napierala M, Panczyk-Tomaszewska M . Carotid intima-media thickness in children with idiopathic nephrotic syndrome: A single center cross-sectional study . Clin Nephrol. 2019; 91(6):353-362. DOI: 10.5414/CN109617. View

19.

Goknar N, Webb H, Waters A, Tullus K . Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?. Pediatr Nephrol. 2021; 37(7):1575-1584. DOI: 10.1007/s00467-021-05288-1. View

20.

Kitamura M . [Growth retardation in children with frequent relapsing nephrotic syndrome on steroid--improvement of height velocity after administration of immunosuppressive agent]. Nihon Jinzo Gakkai Shi. 1992; 34(2):117-24. View